Welcome


The Ludwig Boltzmann Institute Applied Diagnostics (lbi:ad) is a translational research institution of the Ludwig Boltzmann Gesellschaft which is combining a team of transdisciplinary scientists, academic and industrial partners from several countries. It follows a new dual biomarker concept for tumor diagnosis. The focus of the institute lies on the development of non-invasive diagnostic methods combining molecular epigenetic and genetic signatures with molecular imaging biomarkers for PET and SPECT analysis. The combination of these two methods will allow for improved functional, spatial and temporal assessment of tumor load and molecular tumor characterization.


4th National Congress of the Korean Society of Radiopharmaceuticals and Molecular Probes 2017


Prof. Dr. Thomas L. Mindt, Head of Imaging Biomarkers, was invited to deliver the plenary lecture at the 4th national congress
Johannes Längle – Posterpreis der 34. Jahrestagung der Österreichische Gesellschaft für Chirurgische Onkologie (ACO-ASSO)


(Wien, 17-10-2017) Johannes Längle von der Klinischen Abteilung für Allgemeinchirurgie der Universitätsklinik
Der Weinherbst 2017
Der Weinherbst 2017

Beim LBG Weinherbst am 11. Oktober 2017 stellte die Ludwig Boltzmann Gesellschaft zwei Forschungsgruppen vor, die sich mit der psychischen Gesundheit von Kindern mit psychisch

Share This: